A private investment vehicle for a successful entrepreneur that was founded in 2012 and based in Western Europe is currently looking globally for therapeutics. The firm looks to make equity investments into therapeutics companies of up to $5 million initially for approximately 30% equity with additional capital reserved for follow-on rounds. The firm has no set number of allocations that it plans to make but is actively seeking new investments. The firm is looking for companies located around the globe.
The firm is looking for companies in the Therapeutics space developing small molecules or biologics. While the firm prefers companies in clinical trials they are also open to considering preclinical companies with strong animal data. The firm has special interest in diabetes and generally stays away from neurology and cancer, but is open to review all indications and therapeutic types.
The firm evaluates management on a case by case basis and prefers to work with management teams that have domain expertise and experience in their indication area. The firm generally looks to take a board seat following investment.
Next Phase Newsletter 
Leave a comment